Literature DB >> 22222462

Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.

Alessandro Serretti1, Alberto Chiesa, Concetta Crisafulli, Isabelle Massat, Sylvie Linotte, Raffaella Calati, Siegfried Kasper, Ursula Bailer, Yves Lecrubier, Martin Fink, Irina Antonijevic, Carlos Forray, Lenore Snyder, Joseph Bollen, Joseph Zohar, Diana De Ronchi, Daniel Souery, Julien Mendlewicz.   

Abstract

In the present study, we aimed to confirm the previous finding of an association between GRIK4 and GNB3 variants (rs195478 and rs5443) and remission and treatment resistance in major depression, using a multicenter sample of 223 patients. We did not find any supporting evidence for such associations. These conflicting data may result from difficulties in the replication of candidate gene association studies.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22222462     DOI： 10.1159/000329553

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN： 0302-282X            Impact factor:   2.328


  8 in total

Review 1.  Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.

Authors:  Tristram A Lett; Henrik Walter; Eva J Brandl
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

Review 2.  Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

Authors:  Gavin P Reynolds; Olga O McGowan; Caroline F Dalton
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

Review 3.  Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.

Authors:  Bharathi S Gadad; Manish K Jha; Andrew Czysz; Jennifer L Furman; Taryn L Mayes; Michael P Emslie; Madhukar H Trivedi
Journal:  J Affect Disord       Date:  2017-07-05       Impact factor: 4.839

4.  The role of GRIK4 gene in treatment-resistant depression.

Authors:  Elena Milanesi; Cristian Bonvicini; Chiara Congiu; Marco Bortolomasi; Giulio Gainelli; Massimo Gennarelli; Alessandra Minelli
Journal:  Genet Res (Camb)       Date:  2015-07-03       Impact factor: 1.588

5.  GRIK4 polymorphism and its association with antidepressant response in depressed patients: a meta-analysis.

Authors:  Daniel M Kawaguchi; Stephen J Glatt
Journal:  Pharmacogenomics       Date:  2014-08       Impact factor: 2.533

Review 6.  Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders.

Authors:  Rafael T de Sousa; Alexandre A Loch; André F Carvalho; André R Brunoni; Marie Reine Haddad; Ioline D Henter; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Neuropsychopharmacology       Date:  2016-08-11       Impact factor: 7.853

7.  The C825T Polymorphism of the G-Protein β3 Gene as a Risk Factor for Depression: A Meta-Analysis.

Authors:  Liang Fang; Chanjuan Zhou; Shunjie Bai; Chenglong Huang; Junxi Pan; Ling Wang; Xinfa Wang; Qiang Mao; Lu Sun; Peng Xie
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 8.  Genetic variables of the glutamatergic system associated with treatment-resistant depression: A review of the literature.

Authors:  Estela Saez; Leire Erkoreka; Teresa Moreno-Calle; Belen Berjano; Ana Gonzalez-Pinto; Nieves Basterreche; Aurora Arrue
Journal:  World J Psychiatry       Date:  2022-07-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.